In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Aspect Medical nets $105.6mm in convertible debt financing

Executive Summary

Brain monitoring device maker Aspect Medical Systems has netted $105.6mm by selling 2.5% seven-year senior notes to institutional investors under Rule 144A. The notes convert into stock at a rate of 52.4294 shares per $1k notes, or $19.07 per share. (The shares averaged $16.01 at announcement.) Backers also received an option to purchase another $15mm in notes. Aspect plans to use the money to buy back some of its shares sold to Boston Scientific through a 2002 deal that was recently terminated.
Deal Industry
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Convertible Debt

Related Companies

Advertisement
UsernamePublicRestriction

Register